Compare Lustrum:JCR Pharmaceuticals Co.,Ltd.:4552

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index JCR Pharmaceuticals Co.,Ltd. Go to web site 4552 Medicals 東証プライム March 1, 2000 1992.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

JCR Pharmaceuticals Co.,Ltd. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

JCR Pharmaceuticals Co.,Ltd. Balance Sheet 2024年3月期 JCR Pharmaceuticals Co.,Ltd. Balance Sheet 2023年3月期 JCR Pharmaceuticals Co.,Ltd. Balance Sheet 2022年3月期 JCR Pharmaceuticals Co.,Ltd. Balance Sheet 2021年3月期 JCR Pharmaceuticals Co.,Ltd. Balance Sheet 2020年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Cash and Cash Equivalents
(Percent)
18,756up
(18.3%)up
13,278down
(14.0%)down
30,733up
(31.6%)down
26,260up
(35.6%)up
10,973
(23.0%)
Other Current AssetsHelp
(Percent)
38,825up
(38.0%)up
34,524up
(36.4%)up
31,455up
(32.4%)up
22,285up
(30.2%)down
17,369
(36.4%)
Tangible Fixed AssetsHelp
(Percent)
30,040down
(29.4%)down
32,681up
(34.4%)up
26,782up
(27.6%)up
17,172up
(23.3%)down
14,875
(31.1%)
Intangible Fixed AssetHelp
(Percent)
3,496down
(3.4%)down
3,652up
(3.8%)up
2,960down
(3.0%)down
3,232up
(4.4%)up
263
(0.6%)
Investments and OthersHelp
(Percent)
11,109up
(10.9%)down
10,802up
(11.4%)up
5,204up
(5.4%)down
4,835up
(6.6%)down
4,295
(9.0%)
Total AssetsHelp
(Percent)
102,226
(100%)
94,937
(100%)
97,134
(100%)
73,784
(100%)
47,775
(100%)
Total Current LiabilitiesHelp
(Percent)
31,698down
(31.0%)down
37,275down
(39.3%)down
43,300up
(44.6%)up
30,151up
(40.9%)up
11,554
(24.2%)
Total Long-term LiabilitiesHelp
(Percent)
14,350up
(14.0%)up
5,500up
(5.8%)up
2,950down
(3.0%)down
5,250up
(7.1%)down
3,831
(8.0%)
Shareholder's EquityHelp
(Percent)
56,178up
(55.0%)up
52,162up
(54.9%)up
50,884up
(52.4%)up
38,383up
(52.0%)down
32,390
(67.8%)
Total LiabilitiesHelp
(Percent)
102,226
(100%)
94,937
(100%)
97,134
(100%)
73,784
(100%)
47,775
(100%)

JCR Pharmaceuticals Co.,Ltd. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

JCR Pharmaceuticals Co.,Ltd. Profit and Loss Account 2024年3月期 JCR Pharmaceuticals Co.,Ltd. Profit and Loss Account 2023年3月期 JCR Pharmaceuticals Co.,Ltd. Profit and Loss Account 2022年3月期 JCR Pharmaceuticals Co.,Ltd. Profit and Loss Account 2021年3月期 JCR Pharmaceuticals Co.,Ltd. Profit and Loss Account 2020年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Amount of Sales
(Percent)
42,871
(100%)
34,343
(100%)
51,082
(100%)
30,085
(100%)
24,781
(100%)
Total Sales
(Percent)
42,871
(100%)
34,343
(100%)
51,082
(100%)
30,085
(100%)
24,781
(100%)
Cost of SalesHelp
(Percent)
11,620up
(27.1%)up
8,886down
(25.9%)up
10,461up
(20.5%)down
7,812down
(26.0%)down
7,901
(31.9%)
Other Costs and RevenueHelp 25,742up
(60.0%)down
21,684down
(63.1%)up
26,113up
(51.1%)down
15,380up
(51.1%)down
14,201
(57.3%)
Total CostsHelp 37,362 30,570 36,574 23,192 22,102
Net RevenueHelp 31,251up
(72.9%)down
25,457down
(74.1%)down
40,621up
(79.5%)up
22,273up
(74.0%)up
16,880
(68.1%)
Earnings Before TaxHelp 7,244up
(16.9%)up
5,412down
(15.8%)down
19,404up
(38.0%)up
8,653up
(28.8%)up
3,422
(13.8%)
Net IncomeHelp 5,509up
(12.9%)up
3,773down
(11.0%)down
14,508up
(28.4%)up
6,893up
(22.9%)up
2,679
(10.8%)
当期純利益 5,509 3,773 14,508 6,893 2,679

JCR Pharmaceuticals Co.,Ltd. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

JCR Pharmaceuticals Co.,Ltd. Cash Flow Statement 2024年3月期 JCR Pharmaceuticals Co.,Ltd. Cash Flow Statement 2023年3月期 JCR Pharmaceuticals Co.,Ltd. Cash Flow Statement 2022年3月期 JCR Pharmaceuticals Co.,Ltd. Cash Flow Statement 2021年3月期 JCR Pharmaceuticals Co.,Ltd. Cash Flow Statement 2020年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Operating Cash Flow(OFC)Help
(Percent)
9,312up
(91.3%)up
-5,499down
(-26.8%)down
9,289down
(93.8%)up
10,340up
(55.5%)down
4,929
(70.4%)
Investing Cash Flow(ICF)Help
(Percent)
-2,690up
(-26.4%)up
-15,002down
(-73.2%)down
-3,250up
(-32.8%)down
-3,290up
(-17.6%)up
-4,161
(-59.5%)
Financing Cash FlowHelp
(Percent)
-2,031down
(-19.9%)down
1,948up
(9.5%)up
-2,179down
(-22.0%)down
8,304up
(44.5%)up
2,048
(29.3%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
886down
(8.7%)up
1,099up
(5.4%)down
612up
(6.2%)up
-22down
(-0.1%)down
20
(0.3%)
Net Increase and Decrease in Cash and Cash Equivalentsn 5,477up
(53.7%)up
-17,454down
(-85.1%)down
4,472down
(45.2%)down
15,332up
(82.2%)up
2,836
(40.5%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

JCR Pharmaceuticals Co.,Ltd.

Company where related level is highHelp

D.Western Therapeutics Institute, Inc.
MediciNova,Inc
Sumitomo Pharma Co., Ltd.
Perseus Proteomics Inc.
AnGes,Inc.
Modalis Therapeutics Corporation
MORISHITA JINTAN CO.,LTD.
SAWAI PHARMACEUTICAL CO.,LTD.
Immuno-Biological Laboratories Co., Ltd.
Cyfuse Biomedical K.K.